Purchases and Sales Made in Q2 2024 in Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME) during Q2 2024. The information is specifically focused on institutions that hold shares of Prime Medicine, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-95.5K- 88.24% |
$411K - $767K
|
12.7K
$30.8K
|
|
|
Jul 19, 2024
Q2 2024
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-126K- 3.75% |
$543K - $1.01M
|
3.24M
$7.84M
|
|
|
Aug 09, 2024
Q2 2024
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-126K- 3.75% |
$543K - $1.01M
|
3.24M
$7.84M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-127K- 40.9% |
$547K - $1.02M
|
184K
$445K
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-977K- 38.72% |
$4.2M - $7.84M
|
1.55M
$3.74M
|
|
|
Aug 14, 2024
Q2 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-1.3M- 65.13% |
$5.57M - $10.4M
|
694K
$1.68M
|